Pentoxifylline and Endometriosis

Phase 3

Completed

• Conditions: Endometriosis-Associated Infertility
• Interventions: Drug: placebo; Drug: pentoxifylline

• Registration Number: NCT00632697
• Lead Sponsor: Hospital Clinic of Barcelona

Brief Summary

To prove efficacy of an immunomodulator called pentoxifylline in the treatment of endometriosis in infertile patients undergoing laparoscopy surgery

Detailed Description

Not available

Study Timeline

• Study Start: 2001-10
• Primary Completion: 2006-12
• Study Completion: 2006-12
• Status Verified: 2008-03
• Study First Submitted: 2008-03-04
• Study First Submitted QC: 2008-03-10
• Last Update Submitted: 2008-03-10
• Study First Posted: 2008-03-11
• Last Update Posted: 2008-03-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 104

Inclusion Criteria

• Infertile patients having early endometriosis as the only factor of their infertility

Exclusion Criteria

• Previous treatment for endometriosis or patients having pelvic disorders in addition to endometriosis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
2	placebo	-
1	pentoxifylline	-

Primary Outcome Measures

Name	Time	Method
Pregnancy rate	6 months follow-up

Trial Locations

Locations (1)

Hospital Clinic; 🇪🇸 Barcelona, Spain